SA
AGN

Strategic Advisors’s Allergan plc AGN Stock Holding History

Strategic Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,061
Closed -$258K – 150
2017
Q2 		$258K Buy
+1,061
New +$249K 0.12% 131
2017
Q1 		– Sell
-1,024
Closed -$215K – 143
2016
Q4 		$215K Buy
+1,024
New +$212K 0.11% 116

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Strategic Advisors's AGN Position: Q3 2017 in Review

Strategic Advisors sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 1,061 shares — an estimated $258K sold.

Strategic Advisors first reported a position in AGN in Q4 2016 and held it in 2 quarters. The position peaked at $258K in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Strategic Advisors reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Strategic Advisors sold 1,061 Allergan plc shares in Q3 2017, an estimated $258K.
  • Strategic Advisors first reported a position in Allergan plc in Q4 2016 and held it in 2 quarters.
  • Strategic Advisors's Allergan plc position peaked at $258K in Q2 2017.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Strategic Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.